Effect of the dual endothelin receptor antagonist bosentan on untreatable skin ulcers in a patient with diabetes: a case report

INTRODUCTION: Refractory skin ulcers are a major burden in patients with diabetes. Their pathogenesis is multifactorial, and data increasingly implicate endothelin as a mediator of diabetic macro- and microvasculopathy. Here we describe the first reported case of an endothelin receptor antagonist be...

Descripción completa

Detalles Bibliográficos
Autores principales: Álvarez Reyes, Fátima, Luna Gómez, Cristina, Brito Suárez, Manuel
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097146/
https://www.ncbi.nlm.nih.gov/pubmed/21496286
http://dx.doi.org/10.1186/1752-1947-5-151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097146/
https://www.ncbi.nlm.nih.gov/pubmed/21496286
http://dx.doi.org/10.1186/1752-1947-5-151

Ejemplares similares